GB1502312A - Quinolone derivatives - Google Patents

Quinolone derivatives

Info

Publication number
GB1502312A
GB1502312A GB11644/75A GB1164475A GB1502312A GB 1502312 A GB1502312 A GB 1502312A GB 11644/75 A GB11644/75 A GB 11644/75A GB 1164475 A GB1164475 A GB 1164475A GB 1502312 A GB1502312 A GB 1502312A
Authority
GB
United Kingdom
Prior art keywords
compound
alkyl
radical
dihydro
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11644/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB11644/75A priority Critical patent/GB1502312A/en
Priority to IE352/76A priority patent/IE43079B1/en
Priority to ZA761097A priority patent/ZA761097B/xx
Priority to SE7602339A priority patent/SE434394B/xx
Priority to AU11476/76A priority patent/AU1147676A/en
Priority to IL49126A priority patent/IL49126A0/xx
Priority to US05/662,685 priority patent/US4066651A/en
Priority to DK115376A priority patent/DK115376A/da
Priority to LU74594A priority patent/LU74594A1/xx
Priority to DD191915A priority patent/DD124117A5/xx
Priority to FI760729A priority patent/FI760729A/fi
Priority to NL7602834A priority patent/NL7602834A/xx
Priority to HU76IE00000737A priority patent/HU172032B/hu
Priority to CS761804A priority patent/CS188273B2/cs
Priority to NO760993A priority patent/NO760993L/no
Priority to DE19762611824 priority patent/DE2611824A1/de
Priority to FR7608061A priority patent/FR2304342A1/fr
Priority to SU762337250A priority patent/SU648090A3/ru
Priority to PT64921A priority patent/PT64921B/pt
Priority to ES446234A priority patent/ES446234A1/es
Priority to JP51031184A priority patent/JPS51118773A/ja
Priority to BE165404A priority patent/BE839839A/fr
Priority to ES459382A priority patent/ES459382A1/es
Priority to US05/832,613 priority patent/US4138490A/en
Publication of GB1502312A publication Critical patent/GB1502312A/en
Priority to US05/945,596 priority patent/US4187310A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB11644/75A 1975-03-20 1975-03-20 Quinolone derivatives Expired GB1502312A (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB11644/75A GB1502312A (en) 1975-03-20 1975-03-20 Quinolone derivatives
IE352/76A IE43079B1 (en) 1975-03-20 1976-02-23 Quinolone derivatives
ZA761097A ZA761097B (en) 1975-03-20 1976-02-24 Quinolone derivatives
SE7602339A SE434394B (sv) 1975-03-20 1976-02-25 Analogiforfarande for framstellning av kinolonalkansyraderivat
AU11476/76A AU1147676A (en) 1975-03-20 1976-02-27 Quinolone derivatives
IL49126A IL49126A0 (en) 1975-03-20 1976-03-01 Quinolone derivatives
US05/662,685 US4066651A (en) 1975-03-20 1976-03-01 Alkanoic acid 2-quinoline derivatives
DK115376A DK115376A (da) 1975-03-20 1976-03-17 Kinolonderivater
LU74594A LU74594A1 (fr) 1975-03-20 1976-03-18
DD191915A DD124117A5 (fr) 1975-03-20 1976-03-18
FI760729A FI760729A (fr) 1975-03-20 1976-03-18
NL7602834A NL7602834A (nl) 1975-03-20 1976-03-18 Werkwijze voor de bereiding van nieuwe chinolon- derivaten.
CS761804A CS188273B2 (en) 1975-03-20 1976-03-19 Process for preparing 2-oxo-4-quinolylalkanoic acids
HU76IE00000737A HU172032B (hu) 1975-03-20 1976-03-19 Sposob poluchenija al'fa-/1-aril-1,2-digidro-2-okso-khinol-4-il/-alkankarbonovykh kislot
NO760993A NO760993L (fr) 1975-03-20 1976-03-19
DE19762611824 DE2611824A1 (de) 1975-03-20 1976-03-19 Chinolonderivate
FR7608061A FR2304342A1 (fr) 1975-03-20 1976-03-19 Derives de la quinolone
SU762337250A SU648090A3 (ru) 1975-03-20 1976-03-19 Способ получени хинолоновых производных или их солей
PT64921A PT64921B (en) 1975-03-20 1976-03-19 Quinolone derivatives
ES446234A ES446234A1 (es) 1975-03-20 1976-03-20 Procedimiento para preparar derivados de acidos quinolonal- canoicos.
JP51031184A JPS51118773A (en) 1975-03-20 1976-03-22 Quinolone alkane acid derivatives preparation method and pharmaceutical composite containing derivatives
BE165404A BE839839A (fr) 1975-03-20 1976-08-19 Derives de la quinolone
ES459382A ES459382A1 (es) 1975-03-20 1977-06-01 Procedimiento para preparar acidos quinolonpropionicos.
US05/832,613 US4138490A (en) 1975-03-20 1977-09-12 Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives
US05/945,596 US4187310A (en) 1975-03-20 1978-09-25 1,2-Dihydro-2-oxoquinol-4-ylacetic acid derivatives and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11644/75A GB1502312A (en) 1975-03-20 1975-03-20 Quinolone derivatives

Publications (1)

Publication Number Publication Date
GB1502312A true GB1502312A (en) 1978-03-01

Family

ID=9990065

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11644/75A Expired GB1502312A (en) 1975-03-20 1975-03-20 Quinolone derivatives

Country Status (4)

Country Link
BE (1) BE839839A (fr)
ES (1) ES459382A1 (fr)
GB (1) GB1502312A (fr)
ZA (1) ZA761097B (fr)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002895A1 (fr) * 1977-12-29 1979-07-11 Imperial Chemical Industries Plc Dérivés de l'acide phtalazinyl-4-acétique inhibiteurs d'enzymes, compositions pharmaceutiques les contenant et leur procédé de préparation
US5436254A (en) * 1989-02-10 1995-07-25 Otsuka Pharmaceutical Company, Ltd. Carbostyril derivatives
US8252937B2 (en) 2007-09-14 2012-08-28 Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
US8299101B2 (en) 2007-03-07 2012-10-30 Janssen Pharmaceuticals, Inc. 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators
US8399493B2 (en) 2004-09-17 2013-03-19 Janssen Pharmaceuticals, Inc. Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8716480B2 (en) 2009-05-12 2014-05-06 Janssen Pharmaceuticals, Inc. 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US8722894B2 (en) 2007-09-14 2014-05-13 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
US8785486B2 (en) 2007-11-14 2014-07-22 Janssen Pharmaceuticals, Inc. Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US8841323B2 (en) 2006-03-15 2014-09-23 Janssen Pharmaceuticals, Inc. 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
US8906939B2 (en) 2007-03-07 2014-12-09 Janssen Pharmaceuticals, Inc. 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
US9114138B2 (en) 2007-09-14 2015-08-25 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9708315B2 (en) 2013-09-06 2017-07-18 Janssen Pharmaceutica Nv 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors
US10106542B2 (en) 2013-06-04 2018-10-23 Janssen Pharmaceutica Nv Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
US10537573B2 (en) 2014-01-21 2020-01-21 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
US11369606B2 (en) 2014-01-21 2022-06-28 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251528A (en) 1977-12-29 1981-02-17 Imperial Chemical Industries Limited Phthalazin-4-ylacetic acid derivatives
US4393062A (en) 1977-12-29 1983-07-12 Imperial Chemical Industries Plc Pharmaceutical compositions and method for the production of an anti-inflammatory effect
EP0002895A1 (fr) * 1977-12-29 1979-07-11 Imperial Chemical Industries Plc Dérivés de l'acide phtalazinyl-4-acétique inhibiteurs d'enzymes, compositions pharmaceutiques les contenant et leur procédé de préparation
US5436254A (en) * 1989-02-10 1995-07-25 Otsuka Pharmaceutical Company, Ltd. Carbostyril derivatives
US5652247A (en) * 1989-02-10 1997-07-29 Otsuka Pharmaceutical Co., Ltd Carbostyril derivatives
US8399493B2 (en) 2004-09-17 2013-03-19 Janssen Pharmaceuticals, Inc. Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
US8841323B2 (en) 2006-03-15 2014-09-23 Janssen Pharmaceuticals, Inc. 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
US9266834B2 (en) 2006-03-15 2016-02-23 Janssen Pharmaceuticals, Inc. 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
US9067891B2 (en) 2007-03-07 2015-06-30 Janssen Pharmaceuticals, Inc. 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors
US8299101B2 (en) 2007-03-07 2012-10-30 Janssen Pharmaceuticals, Inc. 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators
US8906939B2 (en) 2007-03-07 2014-12-09 Janssen Pharmaceuticals, Inc. 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
US8252937B2 (en) 2007-09-14 2012-08-28 Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
US8722894B2 (en) 2007-09-14 2014-05-13 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
US8748621B2 (en) 2007-09-14 2014-06-10 Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
US11071729B2 (en) 2007-09-14 2021-07-27 Addex Pharmaceuticals S.A. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
US9132122B2 (en) 2007-09-14 2015-09-15 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
US9114138B2 (en) 2007-09-14 2015-08-25 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
US8785486B2 (en) 2007-11-14 2014-07-22 Janssen Pharmaceuticals, Inc. Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9085577B2 (en) 2009-05-12 2015-07-21 Janssen Pharmaceuticals, Inc. 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9226930B2 (en) 2009-05-12 2016-01-05 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
US8716480B2 (en) 2009-05-12 2014-05-06 Janssen Pharmaceuticals, Inc. 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9737533B2 (en) 2009-05-12 2017-08-22 Janssen Pharmaceuticals. Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
US10071095B2 (en) 2009-05-12 2018-09-11 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US10106542B2 (en) 2013-06-04 2018-10-23 Janssen Pharmaceutica Nv Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
US10584129B2 (en) 2013-06-04 2020-03-10 Janssen Pharmaceuticals Nv Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
US9708315B2 (en) 2013-09-06 2017-07-18 Janssen Pharmaceutica Nv 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors
US10537573B2 (en) 2014-01-21 2020-01-21 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
US11103506B2 (en) 2014-01-21 2021-08-31 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
US11369606B2 (en) 2014-01-21 2022-06-28 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Also Published As

Publication number Publication date
BE839839A (fr) 1976-09-20
ZA761097B (en) 1977-02-23
ES459382A1 (es) 1978-11-16

Similar Documents

Publication Publication Date Title
GB1502312A (en) Quinolone derivatives
GB1490306A (en) 3-amino-indazolecarboxylic acid derivatives process for their preparation and their use as medicaments
GB2063249A (en) 4-Phenylphthalazine derivatives
JPH0122267B2 (fr)
ES8603408A1 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
Bundgaard et al. Esters of N, N-disubstituted 2-hydroxyacetamides as a novel highly biolabile prodrug type for carboxylic acid agents
GB2181135A (en) Substituted benzene derivatives
IE36797L (en) 1,5-benzodiazepin-2-one derivatives.
JPS633857B2 (fr)
US4761403A (en) Lipoxygenase inhibiting compounds
US3015661A (en) Decahydroisoquinoline derivatives
AU553826B2 (en) Benzopyran-6-yl ethane-carboxylic acid and derivatives
ES438138A1 (es) Un procedimiento para preparar acidos tioxantion-2-carboxi- licos.
JPS6037099B2 (ja) 新規ピラゾ−ル誘導体及びその製造法
Alberti et al. Radical anions and group IVB organometallic adducts of nitrophenylacetylenes and some halogenated derivatives
GB1473819A (en) Derivatives of imidazo 1,2-a pyridine
CA1130307A (fr) Derives d'acides n-(indanon-7-yl)-oxaminiques a proprietes pharmaceutiques
JPS5714554A (en) Production of 2-(substituted phenoxy)phenylacetic acid
IE46102B1 (en) 5-methylisoxazole-4-carboxylic acid anilides having pharmaceutical activity
DE3265110D1 (en) New compound having antiinflammatory, analgesic and mucoregulating activity, process for its production and relative pharmaceutical compositions
GB1453552A (en) Butyrophenone compounds
IE56920B1 (en) 5-amino-1,2-dithiol-3-one compounds,their preparation and medicinal compositions containing them
JPS5470277A (en) Hydroxyindole derivatives
JPS5775947A (en) Production of 2-(substituted phenoxy)phenylacetic acid
KR830000583B1 (ko) 복소환 치환기를 가진 5-설파모일벤조산 유도체의 제조방법

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930219